Nationwide Laboratories Recalls Phenazopyridine Hydrochloride Tablets Due to Manufacturing Deviations
Nationwide Laboratories is recalling Phenazopyridine Hydrochloride Tablets due to manufacturing deviations that may result in assay or content uniformity failures.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which is a reasonable probability of temporary or medically reversible adverse health consequences. The hazard is a manufacturing deviation affecting potency and uniformity, which fits the Moderate severity criteria for low-risk contamination or voluntary precautionary recalls without reported serious injury.
Plain-English summary
Nationwide Laboratories, LLC is recalling Phenazopyridine Hydrochloride Tablets, USP, 100 mg, 100 count bottles. The affected product is prescription-only and was manufactured for Nationwide Laboratories LLC in Iselin, New Jersey. The recall involves 6,333,669 tablets distributed nationwide in the USA and Puerto Rico.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. The product was manufactured under practices which may result in assay or content uniformity failures. This means the tablets may not contain the correct amount of the active ingredient or may not be consistent in their composition.
Consumers and healthcare providers should stop using the affected lots and return them to the pharmacy or point of purchase. The affected lot numbers are 28161501 (Exp 03/17), 28161502 and 28161503 (Exp 08/17), and 28161601 and 28161602 (Exp 01/18).
The recalled product
- Product
- Phenazopyridine Hydrochloride Tablets, USP, 100 mg, 100 count bottles, Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New Jersey 08830, NDC 42937-701-10.
- Manufacturer
- Nationwide Laboratories, LLC
- Category
- Drug — Prescription Medication
- Affected units
- 6,333,669
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot #: 28161501
- Exp 03/17
- 28161502
- 28161503
- Exp 08/17
- 28161601
- 28161602
- Exp 01/18
Distribution
Part of a larger recall action
This product is one of 4 recalled by Nationwide Laboratories, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Nationwide Laboratories, LLC
See all →- ModerateNationwide Laboratories Recalls Salsalate Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2016-12-07
- ModerateNationwide Laboratories Recalls Phenazopyridine Hydrochloride Tablets Due to CGMP Deviations
FDA (Drugs) · 2016-12-07
- ModerateNationwide Laboratories Recalls Salsalate Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2016-12-07
Same hazard · manufacturing deviation
See all →- ModerateSynjardy XR Tablets Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2026-07-08
- ModerateDuloxetine delayed-release capsules recalled for N-nitroso impurity contamination
FDA (Drugs) · 2026-05-13
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateiVIZIA Dry Eye Lubricant Drops Recalled for Sterility Assurance
FDA (Drugs) · 2026-05-06
- ModerateFurosemide tablets recalled for presence of N-nitroso impurity
FDA (Drugs) · 2026-04-29